PacBio has announced plans to enhance its ... a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology ...

PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the “Special Committee”) has concluded its independent investigation into previously disclosed allegations ...

Collaboration leverages HiFi's unique ability to reveal hidden variants, bringing a new level of precision to early life ...

"PacBio was the first to detect native epigenetic modifications alongside accurate DNA sequencing. With the integration of the CUHK deep learning models, our technology will be able to detect many ...

PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025. First quarter results: Q1 2025Q1 2024Revenue$37.2 million$38.8 ...

“Historically, PacBio has had an advantage in terms of the accuracy of the sequencing reads. ONT has the ability to generate much longer reads, which is very useful for assembling the reads ...

Pacific Biosciences of California ... which is applied in various research domains such as human germline sequencing, plant and animal sciences, infectious diseases, microbiology, oncology ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.

PacBio’s HiFi WGS leverages long-read technology ... a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology ...

MENLO PARK, Calif. and BANGKOK, May 05, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) a leading provider of high-quality, highly accurate sequencing platforms, and Chulalongkorn University ...